Home/Filings/4/0001209191-21-065648
4//SEC Filing

Chan M.P. Eric 4

Accession 0001209191-21-065648

CIK 0001433714other

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 7:52 PM ET

Size

25.5 KB

Accession

0001209191-21-065648

Insider Transaction Report

Form 4
Period: 2021-11-16
Chan M.P. Eric
Chief Accounting Officer
Transactions
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2021-11-166,25081,250 total
    Class B Common Stock (6,250 underlying)
  • Exercise/Conversion

    Class B Common Stock

    2021-11-16+1,875121,187 total
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2021-11-164,6880 total
    Class B Common Stock (4,688 underlying)
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2021-11-166,25056,250 total
    Class B Common Stock (6,250 underlying)
  • Exercise/Conversion

    Class B Common Stock

    2021-11-16+6,250127,437 total
  • Exercise/Conversion

    Class B Common Stock

    2021-11-16+6,250133,687 total
  • Exercise/Conversion

    Class B Common Stock

    2021-11-16+4,688117,749 total
  • Exercise/Conversion

    Class B Common Stock

    2021-11-16+1,563119,312 total
  • Sale

    Class B Common Stock

    2021-11-17$1.78/sh7,629$13,570126,058 total
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2021-11-161,5631,555 total
    Class B Common Stock (1,563 underlying)
  • Exercise/Conversion

    Restricted Stock Units (RSU)

    2021-11-161,8759,375 total
    Class B Common Stock (1,875 underlying)
Footnotes (8)
  • [F1]Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
  • [F2]Represents the weighted average sales price per share. The shares sold at prices ranging from $1.76 to $1.83 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
  • [F3]Each RSU represents a contingent right to receive one (1) share of the Class B Common Stock upon settlement for no consideration.
  • [F4]1/4th of the RSUs vested on November 16, 2018, and the remainder will vest 1/16th quarterly over three years in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
  • [F5]1/16th of the RSUs vested on May 16, 2018, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
  • [F6]1/16th of the RSUs vested on May 16, 2019, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
  • [F7]1/16th of the RSUs vested on May 16, 2020, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.
  • [F8]1/16th of the RSUs vested on May 16, 2021, and the remainder will vest 1/16th quarterly in equal installments, subject to the continuing service of the Reporting Person on each vesting date.

Issuer

CASTLIGHT HEALTH, INC.

CIK 0001433714

Entity typeother

Related Parties

1
  • filerCIK 0001717376

Filing Metadata

Form type
4
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 7:52 PM ET
Size
25.5 KB